05-06-2023 Intermediate risk AML
05-06-2023 Intermediate risk AML Read More »
Acute Myeloid Leukaemia
13-03-2023 Achieving MRD negativity in AML
In this Deep Dive session, Drs Kingsley Lohlun and Karen Shires present on the importance and challenges of minimal residual disease (MRD) assessment in acute myeloid leukemia (AML) patients. Topics
13-03-2023 Achieving MRD negativity in AML Read More »
27-02-2023 Feedback on the 5th EBMT CAR T-cell Meeting
In this Deep Dive session, Drs Erma Gardner, Candice Hendricks and Justin du Toit give feedback from the 5th European Bone Marrow Transplant (EBMT) CAR T-cell Meeting. They focus on
27-02-2023 Feedback on the 5th EBMT CAR T-cell Meeting Read More »